Search Result "177Lu-rituximab"
Effect of Number of Bifunctional Chelating Agents on the Pharmacokinetics and Immunoreactivity of 177Lu-labeled Rituximab: A Systemic Study
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2018 Page: 146-153
Author(s): Mohini Guleria,Tapas Das,Chandan Kumar,Rohit Sharma,Jeyachitra Amirdhanayagam,Haladhar D. Sarma,Ashutosh Dash
Biodistribution and Dosimetry of 177Lu-tetulomab, a New Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma
Journal: Current Radiopharmaceuticals
Volume: 6 Issue: 1 Year: 2013 Page: 20-27
Author(s): Ada H. V. Repetto-Llamazares, Roy H. Larsen, Camilla Mollatt, Michael Lassmann, Jostein Dahle
Defining Pharmacokinetics for Individual Patient Dosimetry in Routine Radiopeptide and Radioimmunotherapy of Cancer: Australian Experience
Journal: Current Pharmaceutical Design
Volume: 15 Issue: 9 Year: 2009 Page: 966-982
Author(s): J. Harvey Turner
Standardization of Procedures for the Preparation of 177Lu- and 90Y-labeled DOTA-Rituximab Based on the Freeze-dried Kit Formulation
Journal: Current Radiopharmaceuticals
Volume: 8 Issue: 1 Year: 2015 Page: 62-68
Author(s): Wioletta Wojdowska,Urszula Karczmarczyk,Michal Maurin,Piotr Garnuszek,Renata Mikolajczak
Development and biological studies of 177Lu-DOTA-rituximab for the treatment of Non-Hodgkinâs lymphoma
Journal: Current Radiopharmaceuticals
Volume: 9 Issue: 1 Year: 2016 Page: 54-63
Author(s): Adriana V.F. Massicano,Priscilla B. Pujatti,Lais F. Alcarde,Miriam F. Suzuki,Patrick J. Spencer,Elaine B. Araújo
Cellular Toxicity and Apoptosis Studies in Osteocarcinoma Cells, a Comparison of 177Lu-EDTMP and Lu-EDTMP
Journal: Current Radiopharmaceuticals
Volume: 6 Issue: 3 Year: 2013 Page: 146-151
Author(s): Chandan Kumar,Aruna Korde,Kusum V. Kumari,Tapas Das,Grace Samuel
Graphical Abstracts:
Journal: Current Radiopharmaceuticals
Volume: 8 Issue: 1 Year: 2015 Page: i-v
Author(s):
Editorial Review of 2014
Journal: Current Radiopharmaceuticals
Volume: 7 Issue: 1 Year: 2014 Page: 1-4
Author(s): Sean L. Kitson,Luigi Mansi
Evolving Important Role of Lutetium-177 for Therapeutic Nuclear Medicine
Journal: Current Radiopharmaceuticals
Volume: 8 Issue: 2 Year: 2015 Page: 78-85
Author(s): Ambikalmajan M.R. Pillai,Furn F. (Russ) Knapp
Targeted Radionuclide Therapy - An Overview
Journal: Current Radiopharmaceuticals
Volume: 6 Issue: 3 Year: 2013 Page: 152-180
Author(s): Ashutosh Dash,F. F. (Russ) Knapp,M. R.A. Pillai